Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Mandela Responding to Lung-Infection Treatment

Former South African President Nelson Mandela
Former South African President Nelson Mandela, seen here in 2007, was admitted to a undisclosed hospital in the capital, Pretoria, on Dec. 8 for a recurring infection. Photographer : Chris Ratcliffe/Bloomberg

Dec. 12 (Bloomberg) -- Doctors treating former South African President Nelson Mandela for a lung infection are “satisfied” with his progress in the past 24 hours, President Jacob Zuma’s office said today.

Mandela, 94, was admitted to a undisclosed hospital in the capital, Pretoria, on Dec. 8 for a recurring infection. He became the nation’s first black president after all-race elections in 1994 that brought an end to white-minority rule. Mandela stepped down voluntarily in 1999.

“Doctors attending to former President Mandela have reported that he has made progress during the past 24 hours and they are satisfied with the way he is responding to treatment,” Zuma’s office said.

Mandela, who spent 27 years in prison for opposing the apartheid government, had exploratory surgery for an abdominal complaint in February and was hospitalized for an acute respiratory infection a year earlier.

To contact the reporter on this story: Andres R. Martinez in Johannesburg at amartinez28@bloomberg.net

To contact the editor responsible for this story: Nasreen Seria at nseria@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.